Sanofi Genzyme News |

Featured Press Releases

November 6, 2018
FDA grants priority review for Dupixent® (dupilumab) as potential treatment for adolescents with uncontrolled moderate-to-severe atopic dermatitis
The U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent® (dupilumab) in adolescent patients 12 to 17 years of age with moderate-to-severe atopic dermatitis, whose disease was inadequately controlled with topical...
October 19, 2018
FDA approves asthma indication for Dupixent® (dupilumab)
The U.S. Food and Drug Administration has approved Dupixent® (dupilumab) as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid-dependent asthma.
October 19, 2018
Kevzara® (sarilumab) data at the 2018 ACR/ARHP Annual Meeting provide additional insight on safety, efficacy in rheumatoid arthritis
Data from analyses of the Kevzara® (sarilumab) Phase 3 clinical development program will be presented at the 2018 ACR/ARHP Annual Meeting, which is being held in Chicago from October 19 to 24.
October 16, 2018
Dupixent® (dupilumab) showed positive topline results in two Phase 3 trials of patients with chronic rhinosinusitis with nasal polyps
Two pivotal Phase 3 placebo-controlled trials evaluating Dupixent® (dupilumab) in adults with inadequately-controlled chronic rhinosinusitis with nasal polyps (“CRSwNP”) met all primary and secondary endpoints.

Leadership

Bill Sibold
Executive Vice President and Head of Sanofi Genzyme
Bill joined Sanofi Genzyme in 2011 as Senior Vice President and Head of Multiple Sclerosis, and oversaw the successful launches of its two MS treatments. As Head of Sanofi Genzyme, he leads the business’s efforts to maintain its leadership in rare diseases while continuing to grow in multiple sclerosis, oncology and immunology. More...

Tweets

Our Torch Awards program recognizes individuals who have made a significant contribution to the LSD community. Nomi… https://t.co/o6FDftPkFa-2 hours 35 min ago

Today and every day, take the time to thank the #caregivers in your life. #NationalFamilyCaregiversMonth https://t.co/fAYRzpp9mW-1 day 4 hours ago

RT @TheDimockCenter: For those who may have missed this engaging interview with our President & CEO Dr. Myechia Minter-Jordan and EVP &… https://t.co/k8wBm53Z80-1 day 19 hours ago

Tune in tomorrow! https://t.co/6wvjnYGBXA-3 days 16 hours ago

Although there are several types of inherited #hemophilia, about 30% of people with the condition have no prior fam… https://t.co/BKCJ7pTCty-4 days 4 hours ago

Search Newsroom

Featured Press Releases

Featured Videos

Leadership

Media Resources

Tweets

Social Media